Feasibility of Identifying Pancreatic Cancer Based on Serum Metabolomics
Open Access
- 1 January 2011
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 20 (1) , 140-147
- https://doi.org/10.1158/1055-9965.epi-10-0712
Abstract
Background: We postulated that the abundance of various metabolites in blood would facilitate the diagnosis of pancreatic and biliary lesions, which could potentially prevent unnecessary surgery.Keywords
All Related Versions
This publication has 29 references indexed in Scilit:
- Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profilesMetabolomics, 2009
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progressionNature, 2009
- HMDB: a knowledgebase for the human metabolomeNucleic Acids Research, 2008
- Prevalence and Clinical Profile of Pancreatic Cancer–Associated Diabetes MellitusGastroenterology, 2008
- Biliary brush cytology: Factors associated with positive yields on biliary brush cytologyWorld Journal of Gastroenterology, 2008
- Pancreatic Cancer–Associated Diabetes Mellitus: Prevalence and Temporal Association With Diagnosis of CancerGastroenterology, 2008
- Discrimination of metabolic profiles of pancreatic cancer from chronic pancreatitis by high‐resolution magic angle spinning 1H nuclear magnetic resonance and principal components analysisCancer Science, 2007
- Targeted Profiling: Quantitative Analysis of 1H NMR Metabolomics DataAnalytical Chemistry, 2006
- The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancerEuropean Journal of Surgical Oncology, 2005
- 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica, 1999